Dreo, B; Prietl, B; Kofler, S; Pfeifer, S; Sourij, H; Moazedi-Fürst, F; Kreuzer, S; D'Orazia, M; Zenz, S; Thiel, J; Stradner, MH; Brezinsek, HP .
Rituximab does not alter expression of co-stimulation marker CD19 on B cells in Systemic Sclerosis patients
Supplementay Issue of Annals of Rheumatic Diseases. 2022; 81(1):1144-1145.-EULAR 2022 - Annual European Congress of Rheumatology; JUN 1-4 2022; Copenhagen.
Doi: 10.1136/annrheumdis-2022-eular.768
Web of Science
FullText
FullText_MUG